FierceBiotech will announce 2012 "Fierce 15" at BioPharm America™ in September

August 8, 2012

Washington, DC; Carlsbad, CA and Boston, MA – August 8, 2012: FierceBiotech, the premier news source for the latest about biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news, will again announce the "Fierce 15" winners at BioPharm America™ to be held September 19–21, 2012 in Boston, MA. EBD Group, the leading partnering firm for the life science industry, will hold the annual event at the Westin Boston Waterfront in collaboration with the Massachusetts Biotechnology Council (MassBio).

"We have worked closely with John at FierceBiotech for many years, and we are thrilled to feature the Fierce 15 award winners again at BioPharm America 2012," said Carola Schropp, President of EBD Group. "The Fierce 15 awards create a lot of excitement, and everyone wants to talk about the business strategies the winning companies used to propel their innovation."

"This is our tenth anniversary edition of the Fierce 15, and we couldn't be more excited about it," said John Carroll, the long-time editor of FierceBiotech. "Even in a difficult funding environment, our Fierce 15 companies stand out with cutting-edge technologies, sharp executive teams and some of the greatest potential I've seen in the past decade. These companies are 'fierce' in the best sense of the word. And we're proud to recognize their achievements against tough odds at BioPharm America, which is joining us in showcasing the awards."

Speaking on TESARO's achievement in being selected as a Fierce 15 winner in 2011, Lonnie Moulder, CEO and Co-Founder of TESARO said, "The BioPharm America international partnering conference [was] the ideal venue for TESARO to receive this recognition and to continue our efforts to build a leading oncology pipeline portfolio via partnering with the world's foremost pharmaceutical and biotechnology companies."

The 2012 Fierce 15 winners will be the feature of a live panel discussion at the event, where a select group drawn from the winners is expected to discuss the current landscape in life sciences and the successful drug development and partnering strategies that placed them at the top of the list. The panel will be held on Wednesday, September 19 at 5:15 pm.

"BioPharm America is the perfect place to recognize companies who are breaking the mold to ensure the biotech industry finds new therapies and cures, new business models. These are the companies in demand at a world class partnering event like BioPharm America," said Robert K. Coughlin, President and CEO of MassBio.

Fierce 15 winners are selected from reader and staff nominations based on criteria requiring status as a privately held drug developer or platform biotech with the potential to have a huge impact on the treatment of human diseases. The FierceBiotech selection committee, led by John Carroll and Executive Editor Ryan McBride, will evaluate individual companies based on their pioneering technology and innovative business models.

FierceBiotech is an internationally recognized daily newsletter reaching more than 90,000 biotech and pharma industry professionals, and provides subscribers with a quick authoritative briefing on the day's top stories, with a special focus on drug discovery and clinical trials.

The full BioPharm America 2012 program can be viewed online at
www.ebdgroup.com/bpa/program/index.php

Registration information for BioPharm America can be found by going to
www.ebdgroup.com/bpa/registration/index.php

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Upcoming Events email!
For Email Marketing you can trust

MassBio